Dysfunctional Immune Regulation in Autoimmune Hepatitis: From Pathogenesis to Novel Therapies
Marta Vuerich(Beth Israel Deaconess Medical Center), Maria Serena Longhi(Beth Israel Deaconess Medical Center)
Cited by 38
Related Papers
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
|Immunological Reviews|2017|901
Autoimmune hepatitis
|The Lancet|2013|279
CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury
|Journal of Hepatology|2017|190